И его применение при заболеваниях легких
жүктеу/скачать 142,06 Kb. Pdf көрінісі
|
1089-757-1-PB
| Clark H., Palaniyar N., Strong P. et al.
Surfactant protein reduces alveo lar macrophage apoptosis in vivo . J. Immunol. 2002; 169 (6): 2892—2899. 74. Clark H. W., Palaniyar N., Hawgood S. et al. A recombinant fragment of human surfactant protein D reduces alveolar macrophage apoptosis and proinflammatory cytokones in mice developing pulmonary emphyse ma. Ann. N. Y. Acad. Sci. 2003; 1010: 113—116. 75. Kaplan J. H., Casey J. A., Savani R. C. et al. Differential response of col lectin deficient mouse models to bleomycin induced lung injury. Appl. Cardiopulm. Pathophysiol. 2004; 13 (1): 51—52. 76. Lewis J., Veldhuizen R. The role of surfactant in the pathophysiology of acute lung injury. Appl. Cardiopulm. Pathophysiol. 2004; 13 (1): 53—55. 77. Clark J. C., Wert S. E., Bachurski C. J. et al. Targeted disruption of the sur factant protein B gene disrupts surfactant homeostasis, causing respira tory failure in newborn mice. Proc. Natl. Acad. Sci. USA 1995; 92 (17): 7794—7798. 78. Nogee L. M., Garnier G., Dietz H. C. et al. A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in mul tiple kindreds. J. Clin. Invest. 1994; 93 (4): 1860—1863. 79. Melton K. R., Nesslein L. L., Ikegami M. et al. SPB deficiency causes res piratory failure in adult mice. Am. J. Physiol. 2003; 285: 543—549. 80. Cochrane C. G. A critical examination of the role of SPB in alveolar expansion, Appl. Cardiopulm. Pathophysiol. 2004; 13 (1): 27—29. 81. Cruz A., Vazquez L., Bernardinjo J. et al. Analysis by scanning force microscopy of the micro and nanostructure of LangmuirBlodgett pul monary surfactant films. Appl. Cardiopulm. Pathophysiol. 2004; 13: 30—31. 82. Cruz A. et al. Effect of pulmonary surfactant protein SPB on the micro and nanostructure of phospholipids films. Biophys. J. 2004; 86: 308—310. 83. Na Nkorn P., Flach C. R., Mendelsohn R. et al. The influence of truncat ed surfactantprotein C (SPC17) on the surface properties of lipid monolayers at the airwater interface. Appl. Cardiopulm. Pathophysiol. 2004; 13 (1): 62—63. 84. Weaver T. E., Conkright J. J. Function of surfactant proteins B and C. Annu. Rev. Physiol. 2001; 63: 555—578. 85. Cotton R. B., Olsson T. Lung mechanics in respiratory distress syndrome. In: Robertson B., Taeusch H. W. (eds.) Surfactant therapy for lung dis ease. Lung biology in health and disease. N. Y.: Marcel Dekker, Inc.; 1995; 84. 121—150. 86. Floros J., Veletza V., Kotikalapudi P. et al. Dinucleotide repeats in the human surfactant protein B gene and respiratory distress syndrome. Biochem. J. 1995; 305: 583—590. 87. Nogee L. M., deMello D. E., Dehner L. P. et al. Deficiency of pulmonary surfac tant protein B in alveolar proteinosis. N. Engl. J. Med. 1993; 328: 406—410. 88. Рейниш М. С., Розенберг О. А. Быстрый метод определения фосфо липидов в амниотической жидкости. Лаб. дело 1978; (2): 98—100. 89. Bernard G. R. et al. The AmericanEuropean consensus conference on ARDS: Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am. J. Respir. Crit. Care Med. 1994; 149: 818—821. 90. Gregory T. J., Longmore W. J., Moxley M. A. et al. Surfactant chemical composition and biophysical activity in acute respiratory distress syn drome. J. Clin. Invest. 1991; 88: 1976—1981. 91. Hallman M., Spragg R., Harrell J. H. et al. Evidence of lung surfactant abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity and plasma myoinositol. J. Clin. Invest. 1982; 70: 673—683. 92. жүктеу/скачать 142,06 Kb. Достарыңызбен бөлісу:
|